EudraLex

European Union

This article is part of a series on the politics and government of the European Union

Parliament President Martin Schulz Largest groups; Joseph Daul: EPP María Badía (Interim): S&D 7th session MEPs (736) 2009–14 term Bureau Vice Presidents Quaestor Conference Legislative procedure

European Council President Herman Van Rompuy Parties List of meetings

Council Presidency Greece Configurations General Foreign Economic Euro Legislative procedure Voting Secretariat Secretary-General Uwe Corsepius COREPER

Commission Barroso Comm. President José M. Barroso Vice Presidents Catherine Ashton Viviane Reding Joaquín Almunia Siim Kallas Neelie Kroes Antonio Tajani Maroš Šefčovič Commissioners Civil Service Secretary-General Catherine Day

Court of Justice Court of Justice General Court Civil Service Tribunal Members Rulings

Central Bank Central Bank President ESCB Euro EMU Eurozone

Court of Auditors Court of Auditors Budget OLAF

Agencies

Other bodies Investment Bank CoR EESC Ombudsman National parliaments

Policies and issues Budget Four Freedoms Economic area Single market Area of FS&J Schengen Policies Agricultural Energy Fisheries Regional Citizenship Identity Pro-Europeanism Euroscepticism Integration Supranationalism Federalism U.S.E. Multi-speed Opt-outs Enhanced co-op Withdrawal

Foreign relations High Representative Catherine Ashton Ext. Action Service Foreign Policy Defence Policy Enlargement

Elections 1979, 1984, 1989 1994, 1999, 2004 2009 (last election) 2014 (next election) Political parties Constituencies Referendums

Law Acquis Primacy Subsidiarity Treaties Fundamental Rights Membership v t e

EudraLex is the collection of rules and regulations governing medicinal products in the European Union.

Volumes

EudraLex consists of 10 volumes:

• Concerning Medicinal Products for Human use:
  • Volume 1 - Pharmaceutical Legislation.
  • Volume 2 - Notice to Applicants.
    • Volume 2A deals with procedures for marketing authorisation.
    • Volume 2B deals with the presentation and content of the application dossier.
    • Volume 2C deals with Guidelines.
  • Volume 3 - Guidelines.

• Concerning Medicinal Products for human use in clinical trials (investigational medicinal products).
  • Volume 10 - Clinical trials.

• Concerning Veterinary Medicinal Products:
  • Volume 5 - Pharmaceutical Legislation.
  • Volume 6 - Notice to Applicants.
  • Volume 7 - Guidelines.
  • Volume 8 - Maximum residue limits.

• Concerning Medicinal Products for Human and Veterinary use:
  • Volume 4 - Good Manufacturing Practices.
  • Volume 9 - Pharmacovigilance.

• Miscellaneous:
  • Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)

Directives

• Directive 65/65/EEC1, requires prior approval for marketing of proprietary medicinal products
• Directive 75/318/EEC, clarifies requirements of 65/65/EEC1 and requires member states to enforce them
• Directive 75/319/EEC, requires marketing authorization requests to be drawn up only by qualified experts
• Directive 93/41/EEC, establishes the European Agency for the Evaluation of Medicinal Products
• Directive 2001/20/EC, defines rules for the conduct of clinical trials
• Directive 2001/83/EC
• Directive 2005/28/EC, defines Good Clinical Practice for design and conduct of clinical trials

See also

• European Union law
• European Union directive
• European Commission
• Directorate-General
• EUR-Lex
• Regulation of therapeutic goods
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
• Good clinical practice
• European Medicines Agency
• EUDRANET
• EudraVigilance
• Title 21 of the Code of Federal Regulations (USA)
• Drug development

References

• Eudralex,The Rules Governing Medicinal Products in the European Union, European Communities Commission. Directorate-General for Industry, Pharmaceuticals and Cosmetics.
  • Vol. 1: Pharmaceutical legislation: medicinal products for human use. ISBN 92-828-2032-7
  • Vol. 2: Notice to applicants: medicinal products for human use. ISBN 0-11-975780-X
  • Vol. 3: Guidelines: medicinal products for human use. ISBN 92-828-2436-5
  • Vol. 4: Good manufacturing practices: medicinal products for human and veterinary use. ISBN 92-828-2029-7
  • Vol. 5: Pharmaceutical legislation: veterinary medicinal products. ISBN 92-828-2037-8
  • Vol. 6: Notice to applicants: veterinary medical products. ISBN 0-11-985351-5
  • Vol. 7. Guidelines: Veterinary medicinal products. ISBN 0-11-985366-3
• Markus Hartmann and Florence Hartmann-Vareilles, The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research?, PLoS Clin Trials. 2006 June; 1(2): e13

External links

• News on Pharmaceuticals, (European Union)
• EudraLex
• EUR-Lex
• Review of pharmaceutical legislation (EU DG Enterprise and Industry)
• Directorate General Enterprise and Industry (European Commission)